Actively Recruiting
Egyptian Hypertrophic Cardiomyopathy Program
Led by Magdi Yacoub Heart Foundation · Updated on 2023-06-01
2000
Participants Needed
1
Research Sites
834 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Egyptian HCM program aims at defining incidence, severity, phenotype, genotype and determinants of the disease in Egypt, and providing state-of-the-art treatment strategies including medical, surgical and interventional procedures which are patient- and disease-specific.
CONDITIONS
Official Title
Egyptian Hypertrophic Cardiomyopathy Program
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with hypertrophic cardiomyopathy and willing to consent to participate in the registry
- Family member of an index patient willing to consent to participate in the registry
You will not qualify if you...
- Refusal to consent to participate in the registry program
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Aswan Heart Centre - Magdi Yacoub Heart Foundation
Aswān, Egypt
Actively Recruiting
Research Team
M
Magdi H Yacoub, FRS OM
CONTACT
S
Shehab M Anwer, MBBCh., MRes
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here